GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day
MEMPHIS, Tenn.--(BUSINESS WIRE)-- GTx, Inc. (GTXI) announced today a webcast discussing Capesaris®(GTx-758) and its potential role in the treatment of advanced prostate cancer in men is scheduled for Friday, February 15th 2013, from 9:00am 10:00am Eastern Time. The presentations will be conducted by an expert faculty panel to include: Phillip Kantoff, MD, Dana-Farber Cancer Institute/Brigham and Womens Hospital; Thomas Flaig, MD, University of Colorado School of Medicine; and Evan Yu, MD, Fred Hutchinson Cancer Research Center.
Register for the live webcast at (http://www.media-server.com/m/p/tseh66fk).
Marc Hanover, 901-523-9700
Source: GTx, Inc.Copyright Business Wire 2013